Searchable abstracts of presentations at key conferences in endocrinology

ea0029p325 | Cardiovascular Endocrinology and Lipid Metabolism | ICEECE2012

Analysis of hyponatremia in a tertiary hospital during a 5 year period

Duran A. , Gomez E. , Molino A. , Granda C. , Marco J.

Aims: Hiponatremia is the most frequent electrolyte disturbance. Our aim is to retrospectively analyze the diagnosis of hyponatremia in the discharge sheets of a tertiary hospital during 5 yearsMethod: Data from the MBDS (Minimum Basic Data Set) of the discharged patients from the Hospital Clínico San Carlos (Madrid) between the years 2005 and 2009 was analysed. The 5th Edition of the ICD-9-CM was used for the codification of the diagnoses and proce...

ea0029p640 | Diabetes | ICEECE2012

Relationship between hyponatremia and diabetes mellitus

Duran A , Cuesta M , Runkle I , de Miguel P , Sotres G , Marco J

Aims: Our aim is to retrospectively analyze the diagnosis of hyponatremia in the discharge sheets of a tertiary hospital during 5 years and its relationship with type 1 and 2 diabetes mellitus.Methods: Data from the MBDS (Minimum Basic Data Set) of the discharged patients from the Hospital Clínico San Carlos (Madrid) between the years 2005 to 2009 was analysed. The 5th Edition of the ICD-9-CM was used for the codification of the diagnoses and proced...

ea0029p265 | Calcium & Vitamin D metabolism | ICEECE2012

Experience in the treatment of primary hyperparathyroidism with cinacalcet: Preliminary data

Luque-Fernandez I. , Garcia-Martin A. , Luque-Pazos A. , Sastre-Marcos J. , Marco-Martinez A. , Vicente-Delgado A. , Pena-Cortes V.

Introduction: Cinacalcet is an oral calcimimetic indicated in treatment of primary hyperparathyroidism if patients do not accept surgery, do not carry out the surgical criteria, there is failure of previous surgery or serious comorbidity that makes surgery impossible.Methods: Descriptive study that included 34 patients with primary hyperparathyroidism treated with cinacalcet. We recorded clinical and biochemical data before and after 6 months of treateme...

ea0056gp202 | Pituitary Clinical | ECE2018

Endoscopic vs microscopic transsphenoidal surgery for Cushing’s disease: a systematic review and meta-analysis

Broersen Leonie H A , Biermasz Nienke R , van Furth Wouter R , de Vries Friso , Verstegen Marco J T , Dekkers Olaf M , Pereira Alberto M

Background: Cushing’s disease is caused by an adrenocorticotropic hormone (ACTH)-secreting pituitary adenoma, resulting in glucocorticoid excess. First-choice treatment is transsphenoidal pituitary surgery, using either a microscopic or endoscopic technique. Convincing evidence supporting the choice for one of both techniques, either based on treatment results or complication rate, is lacking.Objective: We aimed to compare endoscopic and microscopic...